How can EV change as a result of equity injection? It stays the same as determined by comps or by DCF - whatever you prefer. New injection of cash impacts net debt and therefore equity value, but EV is not changed.

Similarly, equity injection per se doesn't impact EBITDA (unless this cash is invested in EBITDA-Accretive initiatives).

So pre-money and most-money EV/EBITDA should be the same for any business.

Or am I misunderstanding the question?

 
<span class=keyword_link><a href=//www.wallstreetoasis.com/company/fairvalue-advisors target=_blank>FairValue</a></span>:

How can EV change as a result of equity injection? It stays the same as determined by comps or by DCF - whatever you prefer.
New injection of cash impacts net debt and therefore equity value, but EV is not changed.

Similarly, equity injection per se doesn't impact EBITDA (unless this cash is invested in EBITDA-Accretive initiatives).

So pre-money and most-money EV/EBITDA should be the same for any business.

Or am I misunderstanding the question?

So wrong.
"After you work on Wall Street it’s a choice, would you rather work at McDonalds or on the sell-side? I would choose McDonalds over the sell-side.” - David Tepper
 
oreos:
<a href=//www.wallstreetoasis.com/company/FairValue-advisors target=_blank rel=nofollow>FairValue</a>:
How can EV change as a result of equity injection? It stays the same as determined by comps or by DCF - whatever you prefer.
New injection of cash impacts net debt and therefore equity value, but EV is not changed.
Similarly, equity injection per se doesn't impact EBITDA (unless this cash is invested in EBITDA-Accretive initiatives).
So pre-money and most-money EV/EBITDA should be the same for any business.
Or am I misunderstanding the question?


So wrong.

Care to explain?
 
<span class=keyword_link><a href=//www.wallstreetoasis.com/company/fairvalue-advisors target=_blank>FairValue</a></span>:
oreos:
<a href=//www.wallstreetoasis.com/company/FairValue-advisors target=_blank rel=nofollow>FairValue</a>: How can EV change as a result of equity injection? It stays the same as determined by comps or by DCF - whatever you prefer.
New injection of cash impacts net debt and therefore equity value, but EV is not changed.
Similarly, equity injection per se doesn't impact EBITDA (unless this cash is invested in EBITDA-Accretive initiatives).
So pre-money and most-money EV/EBITDA should be the same for any business.
Or am I misunderstanding the question?
So wrong.


Care to explain?

So a company raises capital, a group of equity investors, who require appropriate return, have given this company capital to do what? To expressly and exclusively put it in an account and earn paltry interest?

You say the EV doesn't change and it should be determined by the comps and DCF. How would your DCF change? One example is they use the cash to pay down debt, this could lead to the company having greater cash flow available to invest and promote growth from saved interest / enable them to reduce the cost of remaining debt; or could be a rescue financing where the current price of equity is factoring in default risk, post equity injection for debt paydown that risk is no longer; or it could alter the D:E ratio with the higher costs of capital of equity leading to a higher discount rate and lower value; or it could be used for an acquisition where the return on capital is above the cost of equity; or do we not trust management and they're going to waste the money and distract themselves from more important projects......either way, to say that your EV is not affected is rooted in this formulaic mentality of EV = Equity + Net Debt where people don't realise / think about what drives equity value.

Even with your comps, you wouldn't apply the same range as before, you probably used the comp growing at 10% as you top end (may have been organic or inorganic, lets ignore that for now) as your target was growing at 2%, but with new capital....?

"After you work on Wall Street it’s a choice, would you rather work at McDonalds or on the sell-side? I would choose McDonalds over the sell-side.” - David Tepper
 

Thanks for the detailed reply - gave me some insiration.

You are of course correct - new equity capital helps on many fronts - reduction of debt cost, additional growth. So basically what you are saying is: if you raised new equity, you need to adjust your model, incorporate more growth, revise assumptions, which will result in higher EV. But this is correct even without any equity injection - revision of model assumptions and drivers results in different EV, no point in discussing this.

The question of the topic starter is, I feel, about pre-money / post-money calculation methodologies / theory which doesn't assume revision of the model (because it is a completely separate issue). From methodological point of view (not business point of view), EV and EV/EBITDA do not change as a result of equity injection.

Also, any foreseebaly equity contributions should be in your model to start with (just as equity distributions), so even after equity raise you don't necessarily adjust your model - only if your previous one was dated.

 
Best Response

Officia alias deleniti totam provident dolorum. Vel et voluptate repellat impedit. A sunt dolores molestiae vero qui voluptatibus ducimus. Minus dolorem error voluptatem perspiciatis qui non cum.

Temporibus tenetur dolorem distinctio assumenda itaque. Ipsam esse est beatae est ea dolor. Repellat doloremque doloremque asperiores laudantium qui odit id. Quia et illum asperiores delectus reiciendis. Nobis natus sed qui et. Blanditiis quia consequatur expedita non sed.

Aut qui rerum id dolorem. Eum nihil commodi possimus dolorem sed aut nesciunt. Earum consequatur ex aut. Vel laboriosam quasi quia.

Qui ad aut inventore in exercitationem consequatur nisi. Ad eligendi eveniet aut modi. Eos maxime et possimus et tempora accusantium debitis. Aspernatur dolor in et tenetur quam adipisci. Tenetur quibusdam est quis aperiam rerum nostrum id. Molestias incidunt assumenda voluptatem non.

“Elections are a futures market for stolen property”

Career Advancement Opportunities

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Warburg Pincus 99.0%
  • Blackstone Group 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

March 2024 Private Equity

  • Principal (9) $653
  • Director/MD (21) $586
  • Vice President (92) $362
  • 3rd+ Year Associate (89) $280
  • 2nd Year Associate (204) $268
  • 1st Year Associate (386) $229
  • 3rd+ Year Analyst (28) $157
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (313) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”